Budesonide After Esophageal Stretching in Children
Part of Digestive system clinical trials.
This study tests whether a steroid medication called budesonide can help prevent esophageal strictures (abnormal tightening of the swallowing tube) from returning after a stretching procedure in children who were born with a connection between the esophagus and windpipe that was surgically repaired.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 12 years old
- Your child has an esophageal stricture (narrowing) at the surgical repair site from congenital esophageal atresia/tracheoesophageal fistula repair
- Your child has difficulty swallowing that meets a certain severity level
- Your child has not had previous stretching procedures on the stricture
- Your child does not have other strictures besides the one at the repair site
- You are able to provide informed consent and participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a steroid injection to esophageal dilation helps children with narrowings that keep coming back. If you have a child with a stubborn narrowing that has already needed dilation, this treatment might help keep it open longer.
This trial compares two medicines—tranilast and steroids—to see which works better at preventing the esophagus from narrowing after a procedure to remove early growths. If you had this procedure, you may be able to join.
This study tests whether a paclitaxel-coated balloon can keep the esophagus (food pipe) open longer in people with a stubborn benign narrowing. It aims to improve swallowing by reducing how often the narrowing needs repeat stretching.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This trial looks back at patients with epidermolysis bullosa (a condition that makes skin very fragile) who had trouble swallowing and were treated with the drug budesonide. It aims to see if the drug helped improve swallowing after one to three months.
This trial tests a budesonide liquid that targets inflammation in the esophagus, stomach, and duodenum (upper digestive tract) in children with Crohn's disease. It aims to see if this treatment can reduce inflammation in those areas without strong side effects.
Hear when a new Esophageal Stricture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.